FDA approves Merck’s oral cholesterol drug enlicitide, to be sold as Lipfendra
How left and right are reading this
- Both agree
- A first oral PCSK9 inhibitor gives adults with high LDL cholesterol a needle-free new option, even as its effect on heart attacks or strokes remains unproven.
- They split on
- Whether the story is about expanding practical access to cholesterol treatment, or about withholding full confidence until lower LDL is shown to prevent heart attacks or strokes.
The Facts
- The FDA approved enlicitide on Thursday, and Merck will market it under the brand name Lipfendra.
- Lipfendra is a once-daily pill and the first oral drug in the PCSK9 inhibitor class to receive FDA approval.
- The drug is intended for adults with high LDL cholesterol, including some patients whose cholesterol remains elevated despite other treatment.
- Lipfendra works by inhibiting the PCSK9 protein, which helps the body clear LDL cholesterol from the blood.
- Before this approval, PCSK9 inhibitors were available primarily as injectable drugs rather than pills.
- Clinical trials reported by multiple outlets found that adding Lipfendra to statin therapy reduced LDL cholesterol by about 56% to 60%.
- The approval matters because it gives patients a needle-free alternative to injectable PCSK9 drugs, which several reports say are more expensive and may be less convenient for some people.
- An unresolved question is whether the LDL reductions seen with Lipfendra will also reduce heart attacks or strokes; Merck is conducting an ongoing outcomes study.
Analytical frames for this storyTap to explore
Context
How is Lipfendra different from statins?
Statins lower cholesterol by reducing the liver’s production of cholesterol, while Lipfendra is a PCSK9 inhibitor that helps the liver remove more LDL cholesterol from the bloodstream. Reports also describe Lipfendra as an option for patients who need additional LDL lowering beyond what statins alone can provide. NYT,Indian Express,Guardian
Who is the new pill meant for?
Sources say the drug is approved for adults with high LDL cholesterol, including patients with hypercholesterolemia and some hereditary forms such as heterozygous familial hypercholesterolemia. It is described as an add-on to diet, exercise, and other LDL-lowering therapies. Fox News,NY Post,Drugs.com
What do we know about cost and availability?
Multiple reports say Merck expects Lipfendra to reach pharmacies within weeks. Pricing reports put the monthly list price at about $300 to $315, below the roughly $500 to $600 monthly list prices cited for comparable injectable PCSK9 drugs. NYT,Aol,U.S. News & World R…
Facts first. Then every angle.
The day’s biggest stories in one short brief — the facts everyone agrees on, then the competing values behind the headlines. Free in your inbox.
View all 100 sources
Wire services (7)
Independent coverage (50)
wivb4What is the new FDA-approved pill designed to slash choleste...
ProPakistaniNew Pill Could Reduce Cholesterol Among Millions of Pakistan...
NDTVCholesterol Pills That Work Better Than Statins Get Approval...
Fala CanedoEUA autorizam uso de novo medicamento da Merck para controle...
Poder360EUA aprovam pílula da Merck para reduzir colesterol
BlockonomiMerck (MRK) Stock Rallies Following FDA Approval of Breakthr...
India TodayFDA clears first daily pill that could change bad cholestero...
El ConfidencialEEUU aprueba una pastilla que reduce hasta un 60% el coleste...
Bloomberg LíneaFDA aprueba pastilla de Merck para reducir el colesterol: co...
The Indian ExpressExpert Explains | A daily pill that slashes cholesterol: How...
Der AktionärTop-Tipp Merck & Co: Der Gamechanger für Millionen
News18FDA Approves New Once-Daily Pill To Cut Bad Cholesterol: Wha...
The New York TimesLa FDA aprueba la enlicitida para tratar el colesterol: esto...
cnbctv18.comUS FDA approves first oral pill that cuts bad cholesterol by...
The VindicatorFDA approvess first-of-its-kind pill to help cut cholesterol
La Opinión DigitalPíldora para el colesterol recibe la aprobación de la FDA
RenascençaEUA aprovam primeiro medicamento que reduz "mau" colesterol ...
R7 NotíciasNovo remédio aprovado nos EUA reduz em até 60% os níveis de ...
AolFDA approves 1st-of-its-kind pill to reduce cholesterol - AO...
ClevelandCholesterol pill approved by FDA, billed as first of its kin...
Oregon LiveFDA approves first-of-its-kind cholesterol pill, on par with...
The Boston GlobeFDA approves new pill to slash cholesterol levels
Drugs.comLipfendra (enlicitide) FDA Approval History - Drugs.com
The New York TimesWhat to Know About the New Cholesterol Pill and How it Compa...
Yahoo! FinanceFDA approves first-of-its-kind cholesterol pill Lipfendra: W...
Honolulu Star AdvertiserFDA approves new pill to slash cholesterol levels | Honolulu...
Boston HeraldTicker: Slumping AI stocks drag down markets; FDA approves p...
CNN EspañolLa pastilla para el colesterol de Merck obtiene la autorizac...
TelemundoLa FDA aprueba un nuevo tipo de pastilla para reducir el col...
WYFF4FDA approves a first-of-its-kind pill to cut cholesterol in ...
El EconomistaEU autoriza medicamento oral de Merck contra el colesterol, ...
Drugs.comLipfendra: Uses, Dosage, Side Effects & Warnings - Drugs.com
The Manila timesFDA approves a first-of-its-kind pill to cut cholesterol in ...
Washington PostShould you take the powerful new cholesterol pill approved b...
The New York TimesNueva pastilla para reducir los niveles de colesterol: lo qu...
The HillFDA approves first daily pill to drastically lower cholester...
Economic TimesMerck gets US FDA nod for first-in-its-class oral cholestero...
The Philadelphia InquirerFDA approves new pill to slash cholesterol levels
pharmexec.comPharmaceutical Executive Daily: FDA Approves Lipfendra | Pha...
TribLIVENew cholesterol drug could 'transform treatment' -- but stat...
New York PostFDA signs off on Merck's cholesterol-lowering pill -- the fi...
INFOX.ruВыявлен популярный продукт, который значительно уменьшает ри...
GZHComprimido que reduz em até 60% o colesterol "ruim" é aprova...
SanDiegoRedFDA aprueba la primera pastilla diaria para el tratamiento d...
NBC ChicagoNew pill that cuts cholesterol levels gains FDA approval
O GloboEUA aprovam novo comprimido que reduz o colesterol 'ruim' em...
Business StandardUS FDA approves Merck's daily cholesterol pill to sharply lo...
El Mañana de Nuevo LaredoFDA aprueba la primera pastilla diaria para el colesterol ma...
PhillyVoiceFDA approves pill that lowers cholesterol as effectively as ...
Correio BrazilienseNovo remédio aprovado pela FDA reduz colesterol ruim em 60%
About these frames
The Architect: Stability, law, enforcement, institutional design, separation of powers, regulatory process, rule of law. How are order and governance maintained?
The Analyst: Costs, jobs, inflation, growth, incentives, markets, tradeoffs. Follow the money.
The First Responder: Who gets hurt or helped. Quality of life, vulnerable groups, public health, human cost and benefit.
See this differently than someone you know would? Two ways to keep it going.
The dial works on any URL — paste an article you read elsewhere this week.